Published in Cancer Weekly, July 5th, 2005
"The TEL/AML1 (ETV6/RUNX1) fusion gene is the most common genetic rearrangement" in pediatric ALL, hematologists in Israel explained. "Although considered to be a low-risk leukemia, it is associated with a relapse rate of 10%-20%."
"The coexistence of different subclones at diagnosis, based on polymerase chain reaction (PCR) studies of IG/TCR gene rearrangement, with differential response to chemotherapy, was recently reported in this subtype of ALL," noted R. Rothman and colleagues at Chaim Sheba...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.